Tham khảo Atosiban

  1. ↑ Akerlund M, Carlsson AM, Melin P, Trojnar J (1985). “The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin”. Acta Obstet Gynecol Scand 64 (6): 499–504. PMID 4061066. doi:10.3109/00016348509156728. 
  2. ↑ Sanu O, Lamont RF (2010). “Critical appraisal and clinical utility of atosiban in the management of preterm labor”. Ther Clin Risk Manag 6: 191–199. PMC 2861440. PMID 20463780. doi:10.2147/tcrm.s9378. 
  3. ↑ Tractocile-Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/4305/SPC/
  4. 1 2 Chou, PY; Wu, MH; Pan, HA; Hung, KH; Chang, FM (tháng 6 năm 2011). “Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study”. Taiwan J Obstet Gynecol 50 (2): 136–40. PMID 21791296. doi:10.1016/j.tjog.2011.04.003. 
  5. ↑ Lan, VT; Khang, VN; Nhu, GH; Tuong, HM (tháng 9 năm 2012). “Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure”. Reprod Biomed Online 25 (3): 254–60. PMID 22818095. doi:10.1016/j.rbmo.2012.05.014. 
  6. 1 2 Wu, MY; Chen, SU; Yang, YS (tháng 12 năm 2011). “Using atosiban in uterine contractions of early pregnancies after assisted reproduction”. J Formos Med Assoc 110 (12): 800. PMID 22248840. doi:10.1016/j.jfma.2011.11.016. 
  7. ↑ Conde-Agudelo, A; Romero, R; Kusanovic, JP (2011). “Nifedipine in the management of preterm labor: a systematic review and metaanalysis”. Am J Obstet Gynecol 204 (2): 134.e1–134.e20. PMC 3437772. PMID 21284967. doi:10.1016/j.ajog.2010.11.038. 
  8. ↑ Lamont, Ronald F; Kam, KY Ronald (tháng 3 năm 2008). “Atosiban as a tocolytic for the treatment of spontaneous preterm labor”. Expert Review of Obstetrics & Gynecology 3 (2): 163–174. ISSN 1747-4108. doi:10.1586/17474108.3.2.163. 
  9. ↑ Lamont, Ronald F.; Kam, KY Ronald (2008). “Atosiban as a tocolytic for the treatment of spontaneous preterm labor”. Expert Review of Obstetrics & Gynecology 3 (2): 163–174. doi:10.1586/17474108.3.2.163. 
  10. ↑ Lamont, Callum D.; Jørgensen, Jan Stener; Lamont, Ronald F. (2016). “The safety of tocolytics used for the inhibition of preterm labour”. Expert Opinion on Drug Safety 15 (9): 1163–1173. PMID 27159501. doi:10.1080/14740338.2016.1187128. 
  11. ↑ Coomarasamy, A; Knox, EM; Gee, H; Khan, KS (tháng 11 năm 2002). “Oxytocin antagonists for tocolysis in preterm labour -- a systematic review”. Med Sci Monit 8 (11): RA268–73. PMID 12444392. 
  12. ↑ Flenady, Vicki; Reinebrant, Hanna E.; Liley, Helen G.; Tambimuttu, Eashan G.; Papatsonis, Dimitri N. M. (ngày 6 tháng 6 năm 2014). “Oxytocin receptor antagonists for inhibiting preterm labour”. The Cochrane Database of Systematic Reviews (6): CD004452. ISSN 1469-493X. PMID 24903678. doi:10.1002/14651858.CD004452.pub3. 
  13. ↑ Saleh, SS; Al-Ramahi, MQ; Al Kazaleh, FA (tháng 1 năm 2013). “Atosiban and nifedipine in the suppression of preterm labour: a comparative study”. J Obstet Gynaecol 33 (1): 43–5. PMID 23259877. doi:10.3109/01443615.2012.721822. 
  14. ↑ Salim R, Garmi G, Nachum Z, Zafran N, Baram S, Shalev E. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial" Obstet Gynecol 2012 Dec;120(6):1323-31. doi: http://10.1097/AOG.0b013e3182755dff%5B%5D.
  15. ↑ De Heus, R; Mulder, EJ; Derks, JB; Visser, GH (tháng 6 năm 2009). “The effects of thetocolytics atosiban and nifedipine on fetal movements, heart rate and bloodflow”. J Matern Fetal Neonatal Med. 22 (6): 485–90. PMID 19479644. doi:10.1080/14767050802702349. 
  16. ↑ Shim JY, Park YW, YoonBH, Cho YK, Yang JH, Lee Y, Kim A. "Multicentre, parallelgroup, randomised, single-blind study of the safety and efficacy of atosibanversus ritodrine in the treatment of acute preterm labour in Korean women. BJOG 2006Nov;113(11):1228-34.